Forest Ray received his PhD in systems biology from Columbia University, where he developed tools to match drug side effects to other diseases. He has since worked as a journalist and science writer, covering topics from rare diseases to the intersection between environmental science and social justice. He currently lives in Long Beach, California.
Health Canada has approved a self-injectable subcutaneous (under-the-skin) form of Entyvio (vedolizumab) as an at-home maintenance therapy for adults with Crohn’s disease (CD). The approval follows an earlier decision to ... Read more
Rinvoq (upadacitinib), AbbVie‘s investigational anti-inflammatory medicine, was found to be safe and effective in treating adults with moderate-to-severe ulcerative colitis (UC). The medication met all major endpoints in an ongoing ... Read more
Gut microbes found in feces avoid triggering immune reactions that could lead to conditions like inflammatory bowel disease (IBD) by creating a mucus barrier that separates them from immune cells, ... Read more
Specialized cells of the intestine’s outer lining, called tuft cells, reduced chronic intestinal inflammation in a mouse model of Crohn’s disease when activated by the body’s own gut bacteria, according to ... Read more
A high rate of DNA damage in colon cells underlies the increased risk for colorectal cancer associated with inflammatory bowel disease (IBD), according to a recent study. The study, “Somatic ... Read more